In clinical setting, MUC1 overexpression and genomic alterations were associated with significantly worse overall survival, cancer-specific survival, and recurrence-free survival confirming MUC1 as a survival-related prognostic factor in ccRCC. The gene discussed is MUC1; the disease is cancer.